FDA Plan Could Lead To Faster Review Times For Biologics
By Kim Coghill
Monday, September 9, 2002
The FDA intends to speed the review time of biologics by transferring the application process from the biologics center to the drug center.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.